Webex Link: https://uwhealth.webex.com/uwhealth/j.php?MTID=m398b5099541b81f1b40740bd5e213c1f

Learning Objectives:

  • Describe the pathophysiology, classification, and general management strategies for patients with ACS
  • Identify key pharmacotherapy updates in the 2025 ACS Guidelines and analyze how these differ from previous recommendations
  • Evaluate clinical trials referenced in the 2025 ACS Guidelines that support new or revised pharmacologic recommendations
  • Apply updated guideline recommendations when selecting appropriate pharmacotherapy (antiplatelets, lipid-lowering agents) for patients with ACS
Session date: 
05/08/2025 - 2:00pm to 3:00pm CDT
Location: 
In-person and Virtually
Will be determined by room availability
600 Highland Ave
Madison, WI 53705
United States
See map: Google Maps
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
Add to calendar: 
Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Spencer Heggen, PharmD